YiChang HEC ChangJiang Ph... (YIHCF)

PNK: YIHCF · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: May 01, 2025, 8:00 PM

YiChang HEC ChangJiang Pharmaceutical Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	5.54B	6.29B	5.66B	3.74B	2B	913.79M	466.65M	2.35B	5.24B	6.22B	4.1B	2.51B	2.42B	1.6B	1.05B	941.5M	865.67M
Cost of Revenue	1.17B	1.31B	1.21B	898.88M	661.28M	430.09M	102.78M	354.18M	824.25M	921.82M	610.25M	398.81M	397.77M	280.42M	199.56M	214.23M	215.66M
Gross Profit	4.37B	4.99B	4.45B	2.85B	1.34B	483.7M	363.88M	1.99B	4.41B	5.3B	3.49B	2.11B	2.02B	1.32B	848.57M	727.27M	650.02M
Operating Income	1.82B	2.44B	1.56B	322.72M	280.12M	-458.11M	-570.88M	833.69M	2.14B	2.53B	1.64B	1.08B	1.14B	762.48M	511.5M	419.57M	400.31M
Interest Income	62.84M	164.98M	243.21M	274.91M	255.12M	232.46M	221.31M	219.22M	200.09M	168.47M	86.43M	13.18M	16.93M	14.96M	7.24M	9.1M	12.33M
Pretax Income	1.68B	2.13B	1.34B	39.42M	-115.38M	-667.18M	-335.61M	1.01B	1.85B	2.27B	1.53B	1.1B	1.14B	748.2M	546.86M	453.07M	396M
Net Income	1.65B	1.99B	1.14B	76.6M	-113.42M	-587.65M	-285.08M	839.46M	1.57B	1.92B	1.28B	942.54M	979.78M	647.1M	467.47M	380.6M	327.49M
Selling & General & Admin	1.89B	1.94B	1.8B	1.55B	1.1B	883.25M	1.09B	1.47B	2.4B	2.87B	1.84B	1.04B	896.99M	565.08M	321.68M	313.6M	274.09M
Research & Development	359.95M	192.29M	186.97M	129.61M	127.89M	136.65M	114.11M	119.43M	163.86M	162.62M	170.32M	224.1M	180.4M	96.92M	62.42M	64.24M	56.98M
Other Expenses	296.71M	359.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.55B	2.67B	2.87B	2.53B	1.2B	918.42M	674.8M	960.9M	2.36B	2.86B	1.89B	1.02B	904.08M	583.4M	304.44M	275.07M	241.69M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	1.45B	1.55B	1.44B	1.22B	795.84M	521.67M	725.95M	1.15B	1.93B	2.36B	1.44B	653.65M	586.89M	372.09M	188.73M	180.89M	146.61M
Cost & Expenses	3.72B	3.97B	4.08B	3.43B	1.87B	1.35B	777.58M	1.32B	3.18B	3.79B	2.5B	1.42B	1.3B	863.82M	504M	489.31M	457.35M
Income Tax Expense	161.82M	270.94M	243.81M	9.82M	5.71M	82.99M	113.16M	173.02M	290.5M	361.87M	277.5M	201.11M	194.95M	121.84M	85.97M	72.47M	68.51M
Shares Outstanding (Basic)	879.97M	883.6M	879.97M	879.97M	819.95M	879.97M	874.19M	2.32B	980.31M	960.67M	891.19M	904.05M	904.05M	904.05M	903.57M	901.65M	901.62M
Shares Outstanding (Diluted)	879.97M	879.97M	879.97M	879.97M	879.97M	879.97M	879.97M	1.11B	1.1B	1.13B	891.19M	904.05M	904.05M	904.05M	903.57M	901.64M	901.61M
EPS (Basic)	1.87	2.26	1.29	0.08	-0.13	-0.67	-0.48	0.73	1.62	2.08	1.43	1.04	1.08	0.71	0.51	0.42	0.40
EPS (Diluted)	1.87	2.26	1.29	0.08	-0.13	-0.67	-0.38	0.76	1.40	1.93	1.43	1.04	1.08	0.71	0.51	0.42	0.40
EBITDA	10.51B	3.16B	1.93B	691.48M	590.55M	-206.55M	-388.51M	950.24M	2.23B	2.61B	1.72B	1.14B	1.2B	806.27M	542.57M	447.01M	426.48M
EBIT	2.12B	2.78B	1.55B	322.72M	280.12M	-458.11M	-570.88M	833.69M	2.14B	2.53B	1.64B	1.08B	1.14B	762.48M	511.5M	419.57M	400.31M
Depreciation & Amortization	8.38B	382.3M	383.31M	368.76M	310.43M	251.55M	182.38M	116.54M	87.93M	81.83M	77.06M	61.09M	54.26M	43.8M	31.06M	27.45M	26.16M